Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 452 results found. Search for [ coronavirus vaccine developed in India ]

Results 60 to 80 of 452
Shailendra Shukla
New Delhi, November 5, 2020
MSMEs business activity reaching near-normal levels: ReportBusiness activity of the micro, small and medium enterprises - which are regarded as the backbone of Indian economy - is fast reaching near-normal levels, and rapidly adopting digital business tools to drive efficiency and growth, according to a report. Out of 36, 16 states and UTs are witnessing business activity levels higher than pre-COVID times, while Karnataka, Maharashtra, Gujarat, Andhra Pradesh, Tamil Nadu and Delhi are trend...


BusinessToday.In
November 4, 2020
COVID-19 vaccine update: Based on the success of the trials and regulatory approvals, we can expect vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious, says SII CEO Adar Poonawalla


BusinessToday.In
November 4, 2020
India has vaccine deals with Serum Institute of India that is manufacturing doses of the University of Oxford-AstraZeneca vaccine as well as the candidate by Novavax


BusinessToday.In
November 4, 2020
NASA astronaut Kate Rubins cast her vote from the International Space Station, which is 250 miles from Earth's surface


Reuters
November 4, 2020
Coronavirus vaccine: \"I'm optimistic that we could reach that point before the end of this year,\" Andrew Pollard said of presenting trial results this year


PTI
November 4, 2020
Rik Mehta garnered 37.9 per cent of the votes at 1,071,726, while Booker got 60.6 per cent with 1,714,375 votes


BusinessToday.In
November 4, 2020
47-year-old, Krishnamoorthi, defeated Preston Nelson of the Libertarian Party. Born in New Delhi, Krishnamoorthi has been re-elected to the US House of Representatives for the third consecutive term


BusinessToday.In
November 4, 2020
Scientists have developed a vaccine candidate for COVID-19 that produces high levels of antibodies and better immune response in animals. J&J vaccine trials have resumed in Brazil and Mexico has received coronavirus vaccine from CanSino Biologics for late-stage trials


BusinessToday.In
November 4, 2020
Sheikh Mohammed was administered a shot of the coronavirus vaccine that was developed by the Chinese pharma giant Sinopharm


BusinessToday.In
November 3, 2020
German biotech firm CureVac has revealed its vaccine candidate has triggered an immune response during its phase 1 trials. The UK government has also started the process of the rolling review of AstraZeneca's candidate


PTI
November 1, 2020
Bharat Biotech Executive Director Sai Prasad said the price of the vaccine is yet to be determined, as the company is still looking at the cost of product development


BusinessToday.In
October 29, 2020
Dr Reddy's and Russian Direct Investment Fund (RDIF) joined hands to carry out clinical trials and distribute 100 million doses of Sputnik V vaccine across India


BusinessToday.In
October 29, 2020
Adar Poonawalla claimed there was no immediate concern about the safety of the Oxford vaccine, adding that early indicators have been positive. However, Poonawalla said it will take a year or two to be certain that the vaccine has long-term effect


BusinessToday.In
October 28, 2020
Kate Bingham, the chair of the UK government's vaccine taskforce said that a COVID-19 vaccine could be rolled out in Britain for some people before Christmas but an early 2021 launch is more likely


Vivek Punj
New Delhi, October 28, 2020
Govt extends Unlock 5.0 guidelines till November 30The Unlock 5 guidelines issued by the Ministry of Home Affairs (MHA) on September 30 will remain in force up to November 30, the government said on Tuesday. The lockdown, however, will continue to be implemented strictly in the containment zones till November 30, 2020, it said.Hero MotoCorp to sell, develop Harley-Davidson bikes in India; deal signedHarley-Davidson and Hero MotoCorp on Tuesday announced that the two are entering into a par...


PB Jayakumar & Joe C Mathew
October 26, 2020
Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 2020


BusinessToday.In
October 26, 2020
The outcome of immunogenicity blood tests conducted on a subgroup of older study participants echoed data published in July this year that revealed that the coronavirus vaccine produced robust immune responses in healthy adults aged 18-55 years


PB Jayakumar | Joe C Mathew
October 25, 2020
Coronavirus vaccine administered through the intramuscular injection route protects the lower lungs but not the upper lung. Nasal vaccines can protect the lungs completely and stop transmission and also infection


BusinessToday.In
October 25, 2020
COVID-19 vaccine: The deliberations by the high-level National Expert Vaccine Group on Vaccine Administration comes after Prime Minister Narendra Modi underscored the geographical span of the country


Associated Press
October 25, 2020
Coronavirus vaccine update: Testing of the AstraZeneca vaccine, developed with Oxford University, has already resumed in the United Kingdom, Brazil, South Africa and Japan


PAGES 4 OF 23  12345